MoneyWorks4Me

Shree Ganesh Biotech (India) informs about revised disclosures

19 Jan 2024 Evaluate
Shree Ganesh Biotech (India) has informed that it enclosed the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shiv Corporation.

The above information is a part of company’s filings submitted to BSE.

Peers